D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Alibaba
BABA
|
+$655M |
| 2 |
NVIDIA
NVDA
|
+$579M |
| 3 |
Amazon
AMZN
|
+$425M |
| 4 |
ConocoPhillips
COP
|
+$423M |
| 5 |
Johnson & Johnson
JNJ
|
+$380M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$868M |
| 2 |
Meta Platforms (Facebook)
META
|
+$554M |
| 3 |
Apple
AAPL
|
+$461M |
| 4 |
CELG
Celgene Corp
CELG
|
+$339M |
| 5 |
Pfizer
PFE
|
+$316M |
Sector Composition
| 1 | Technology | 19.2% |
| 2 | Consumer Discretionary | 16.83% |
| 3 | Healthcare | 16.01% |
| 4 | Industrials | 8.99% |
| 5 | Financials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Repligen
RGEN
$6.7B
| $18.3M | 0.02% |
212,970
-51,001
| -19% | -$4.38M |
|
602
Alkermes
ALKS
$4.54B
| $18.3M | 0.02% |
810,821
+463,063
| +133% | +$10.4M |
|
603
Teradata
TDC
$2.03B
| $18.3M | 0.02% |
509,697
+160,107
| +46% | +$5.74M |
|
604
AutoNation
AN
$8.55B
| $18.2M | 0.02% |
434,058
+15,841
| +4% | +$664K |
|
605
SM Energy
SM
$3.11B
| $18.2M | 0.02% |
1,453,732
+337,996
| +30% | +$4.23M |
|
606
3D Systems Corporation
DDD
$287M
| $18.2M | 0.02% |
1,996,537
-601,415
| -23% | -$5.47M |
|
607
Boston Scientific
BSX
$155B
| $18.2M | 0.02% |
422,523
-227,153
| -35% | -$9.76M |
|
608
CareDx
CDNA
$724M
| $18.1M | 0.02% |
503,099
+349,920
| +228% | +$12.6M |
|
|
AVTA
609
DELISTED
Avantax, Inc. Common Stock
AVTA
| $18.1M | 0.02% |
594,416
-33,526
| -5% | -$1.02M |
|
|
CIT
610
DELISTED
CIT Group Inc.
CIT
| $18M | 0.02% |
342,630
+180,661
| +112% | +$9.49M |
|
611
Travere Therapeutics
TVTX
$2.23B
| $17.9M | 0.02% |
891,667
+33,078
| +4% | +$665K |
|
612
Estee Lauder
EL
$31.3B
| $17.8M | 0.02% |
97,339
+30,079
| +45% | +$5.51M |
|
613
Boston Beer
SAM
$2.41B
| $17.8M | 0.02% |
47,173
-1,439
| -3% | -$544K |
|
|
SGI
614
Somnigroup International Inc.
SGI
$18.1B
| $17.8M | 0.02% |
969,320
-213,048
| -18% | -$3.91M |
|
615
SPS Commerce
SPSC
$4.27B
| $17.8M | 0.02% |
347,530
-138,006
| -28% | -$7.05M |
|
616
Paylocity
PCTY
$9.48B
| $17.8M | 0.02% |
189,233
-41,321
| -18% | -$3.88M |
|
617
Credit Acceptance
CACC
$5.91B
| $17.7M | 0.02% |
36,612
+3,006
| +9% | +$1.45M |
|
618
SLM Corp
SLM
$6.04B
| $17.7M | 0.02% |
1,821,654
+839,576
| +85% | +$8.16M |
|
619
Equinor
EQNR
$61B
| $17.7M | 0.02% |
+894,840
| New | +$17.7M |
|
620
Exelon
EXC
$43.8B
| $17.6M | 0.02% |
514,528
+503,796
| +4,694% | +$17.2M |
|
621
Telus
TU
$24.4B
| $17.6M | 0.02% |
950,000
-607,400
| -39% | -$11.2M |
|
622
Signet Jewelers
SIG
$3.79B
| $17.5M | 0.02% |
979,992
+21,570
| +2% | +$386K |
|
|
ATSG
623
DELISTED
Air Transport Services Group, Inc.
ATSG
| $17.2M | 0.02% |
705,519
-77,367
| -10% | -$1.89M |
|
|
COWN
624
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $17.2M | 0.02% |
1,001,408
+254,898
| +34% | +$4.38M |
|
625
Inspire Medical Systems
INSP
$2.44B
| $17.2M | 0.02% |
283,744
-3,232
| -1% | -$196K |
|